Clinical trials: Tracheobronchitis, active
Nosocomial Infection, Nosocomial Pneumonia
Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
Multicenter, randomized open label clinical trial to evaluate IEM and HS as concomitant therapy for respiratory tract infection in patients under artificial ventilation in the ICU.
- Conditions
- Nosocomial Infection, Nosocomial Pneumonia, Tracheobronchitis, Mechanical Ventilation Complication
- Trial name
- ABSENTA (NCT06310941)
- Testing
- Mechanical insufflation-exsufflation, Standard of Care, Hypertonic saline with hyaluronic acid
- Where
- 8 sites in Spain
- Volunteers
- 100 people
- Sponsor
- Hospital San Carlos, Madrid
Ventilator Associated Pneumonia, Tracheobronchitis
A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill Children
The objective of this study is to evaluate implementation of diagnostic stewardship programs as a strategy to safely reduce antibiotic use, and to generate evidence and tools to support dissemination of diagnostic stewardship…
- Trial name
- BrighT STAR (NCT04987840)
- Where
- 8 sites in United States
- Volunteers
- 15 people
- Sponsor
- Johns Hopkins University
Ventilator Associated Tracheobronchitis, Tracheobronchitis
Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation
The Ventilator Associated tracheobronchitis Initiative to Conduct Antibiotic evaluation (VATICAN) trial is a national, multicenter, non-inferiority trial in ICU patients comparing antibiotic treatment for 7 days versus clinical…
- Trial name
- VATICAN (NCT05266066)
- Testing
- Clinical observation without antibiotic therapy for VAT, 7 day antibiotic course for VAT
- Where
- 16 sites in Brazil
- Volunteers
- 590 people
- Sponsor
- Hospital Sirio-Libanes
Ventilator-Associated Pneumonia, Ventilator-Associated Tracheobronchitis
Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis
The primary objective of the AMIVAT trial is to assess whether a 5-day course of inhaled amikacin, compared to placebo, reduces the incidence of progression to ventilator-associated pneumonia (VAP) at day 28 in intensive care…
- Trial name
- AMIVAT (NCT07665788)
- Testing
- Optimized and protocolized nebulization procedure.
- Where
- 17 sites in France
- Volunteers
- 250 people
- Sponsor
- University Hospital, Tours